Source link : https://newshealth.biz/health-news/ev-pembro-beats-soc-in-cisplatin-ineligible-bladder-cancer/
Muscle-invasive bladder cancer patients who are ineligible or refuse cisplatin chemotherapy see “dramatic” improvements in survival outcomes with enfortumab vedotin plus pembrolizumab. Medscape Medical News Source link : https://www.medscape.com/viewarticle/ev-pembro-beats-soc-cisplatin-ineligible-bladder-cancer-2025a1000sgy?src=rss Author : Publish date : 2025-10-20 19:09:00 Copyright for syndicated content belongs to the linked Source.
The post EV + Pembro Beats SOC in Cisplatin-Ineligible Bladder Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-10-20 19:09:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8